During the past decade, Infectious Disease Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Infectious Disease Research Institute" #1 sponsor was "Abbott" with 2 trials, followed by "Agouron Pharmaceuticals" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Dupont Merck" with 1 trials sponsored and "Glaxo Wellcome" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Infectious Disease Research Institute" are "HIV Infections" (8 trials) and "HIV Seronegativity" (1 trials). Many other conditions were trialed in "Infectious Disease Research Institute" in a lesser frequency.

Most popular intervention types in "Infectious Disease Research Institute" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (3 trials), "Nelfinavir mesylate" (3 trials), "Lamivudine/Zidovudine" (2 trials), "Lopinavir/Ritonavir" (2 trials) and "Stavudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Infectious Disease Research Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Infectious Disease Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Infectious Disease Research Institute, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Infectious Disease Research Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".